trial

The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia

NCTId NCT01045720
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Unknown
Enrollment 45 (estimated)
Sponsored by Taichung Veterans General Hospital
Primary completion 2010-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Unknown
Enrollment
45 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2010-01
Primary completion
2010-03
Eligibility
ALL · 20 Years

Interventions & indications

Drugs
Suo Quan Wan, Wu Lin San

Sponsors

Taichung Veterans General HospitalLead Sponsor

Investigators

1
Tsuo-Hung Lan, MD., PhD.Study Director

Sites

1 total
Taichung, Taiwan

Linked catalysts

1
The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Sch — primary completion2010-03

Facts & assertions

4 sourced
Enrollment
45
Phase
PHASE2
Primary Completion Date
2010-03
Status
UNKNOWN
relationships
The graph out of here
drug
Suo Quan Wan, Wu Lin San
drug
lead_sponsor
Taichung Veterans General Hospital
company
indication
Hypersalivation
indication
Clozapine
indication
Schizophrenia
indication
investigator
Tsuo-Hung Lan, MD., PhD.
person